Agenus
AGEN
#9151
Rank
NZ$0.23 B
Marketcap
NZ$5.57
Share price
-4.86%
Change (1 day)
-43.60%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2025 (TTM): NZ$35.28 Million

According to Agenus 's latest financial reports the company's current earnings are NZ$0.10 Billion. In 2024 the company made an earning of -NZ$0.2 Billion, an increase over its 2023 earnings that were of -NZ$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$35.28 M-117.85%
2024 -NZ$0.2 Billion-28.13%
2023 -NZ$0.28 Billion-5.5%
2022 -NZ$0.3 Billion-556.26%
2021 NZ$63.8 M-130.37%
2020 -NZ$0.22 Billion73.75%
2019 -NZ$0.13 Billion-48.74%
2018 -NZ$0.24 Billion34.32%
2017 -NZ$0.18 Billion-7.16%
2016 -NZ$0.19 Billion26.55%
2015 -NZ$0.15 Billion110.24%
2014 -NZ$71.1 Million49.12%
2013 -NZ$47.68 Million
2011 -NZ$32.92 Million-12.25%
2010 -NZ$37.52 Million-21.41%
2009 -NZ$47.74 Million-26.86%
2008 -NZ$65.27 Million13.72%
2007 -NZ$57.4 Million-33.4%
2006 -NZ$86.19 Million-31.84%
2005 -NZ$0.13 Billion9.74%
2004 -NZ$0.12 Billion-0.8%
2003 -NZ$0.12 Billion17.37%
2002 -NZ$98.96 Million37.83%
2001 -NZ$71.8 Million55.99%
2000 -NZ$46.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.80 B 125,627.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.68 B 63,550.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.55 B 46,345.34%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$17.26 B 48,350.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-NZ$0.5 Billion-1,490.73%๐Ÿ‡บ๐Ÿ‡ธ USA